|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$116
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$317,262
|
$31,726
|
Tosato, Giovanna
|
CCR (NCI)
|
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$21,889
|
Barr, Frederic
|
CCR (NCI)
|
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,497,944
|
$724,898
|
Custer, Mary
|
CCR (NCI)
|
|
|
Biochemical Basis of T Cell Activation
|
ZIA BC 010304
|
$1,345,687
|
$672,843
|
Samelson, Lawrence
|
CCR (NCI)
|
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$474,811
|
$23,741
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
|
Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation
|
5R01CA174794-05
|
$605,760
|
$605,760
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,562,883
|
$78,144
|
Restifo, Nicholas
|
CCR (NCI)
|
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133-04180
|
$390,015
|
$7,800
|
Linet, Martha
|
DCEG (NCI)
|
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
$733
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
$1,250
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$24,467
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
3P30CA021765-38S1
|
$134,625
|
$10,770
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
3P30CA021765-38S2
|
$174,253
|
$13,940
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
5P30CA021765-38
|
$6,063,271
|
$485,062
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Cancer Risk in Solid Organ Transplant Recipients
|
ZIA CP010150-10362
|
$143,962
|
$7,198
|
Engels, Eric
|
DCEG (NCI)
|
|
|
CCR Genomics Core
|
ZIC BC 011623
|
$850,744
|
$85,074
|
Conner, Elizabeth
|
CCR (NCI)
|
|
|
CCSS circulatory disease
|
ZIA CP010132-10623
|
$8,676
|
$1,735
|
Little, Mark
|
DCEG (NCI)
|
|
|
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
|
1R01CA213138-01
|
$395,738
|
$130,594
|
M?SCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Characterization of the hematopoietic stem cell lineage
|
ZIA BC 011505
|
$42,694
|
$6,404
|
Lewandoski, Mark
|
CCR (NCI)
|
|
|
Childhood Cancer Survivor Study
|
2U24CA055727-23
|
$3,616,741
|
$361,674
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Childhood cancer survivor study (CCSS)
|
ZIA CP010131-04033
|
$193,574
|
$29,036
|
Morton, Lindsay
|
DCEG (NCI)
|
|
|
Children's Oncology Group Statistics and Data Center
|
5U10CA180899-04
|
$7,008,867
|
$700,887
|
DEVIDAS, MEENAKSHI
|
UNIVERSITY OF FLORIDA
|
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-10S1
|
$300,000
|
$78,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors
|
1R01CA204258-01A1
|
$675,579
|
$94,581
|
NICHOLS, HAZEL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
CLL Families-Mayo
|
ZIA CP004410-10312
|
$36,253
|
$1,813
|
Caporaso, Neil
|
DCEG (NCI)
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-04S1
|
$1,393,520
|
$55,741
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-04
|
$22,547,116
|
$901,885
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Collecting multiple primary tumor tissues
|
ZIA CP010131-10719
|
$30,688
|
$3,069
|
Morton, Lindsay
|
DCEG (NCI)
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-48S1
|
$142,498
|
$2,850
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
$52,912
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
$600
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
$115,928
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S1
|
$112,500
|
$1,125
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
|
Dermatology Consultation Service
|
ZID BC 011317
|
$253,127
|
$75,938
|
Cowen, Edward
|
CCR (NCI)
|
|
|
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
|
ZID BC 011792
|
$418,466
|
$20,923
|
Pack, Svetlana
|
CCR (NCI)
|
|
|
Development of fully-human anti-CD30 chimeric antigen receptors
|
ZIA BC 011660
|
$67,909
|
$54,327
|
Kochenderfer, James
|
CCR (NCI)
|
|
|
Development of Novel Therapies for HIV Infection
|
ZIA SC 006737
|
$47,818
|
$13,867
|
Yarchoan, Robert
|
CCR (NCI)
|
|
|
DNA repair
|
ZIA BC 010283
|
$1,182,201
|
$200,974
|
Nussenzweig, Andre
|
CCR (NCI)
|
|
|
Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation
|
2R01CA047006-30
|
$532,500
|
$266,250
|
Zhao, Bo
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$2,035,321
|
$203,532
|
Gress, Ronald
|
CCR (NCI)
|
|
|
Familial case-control study of lymphoproliferative malignancies and auto-immune d
|
ZIA CP005803-00355
|
$3,239
|
$648
|
Goldin, Lynn
|
DCEG (NCI)
|
|
|
Follow-up studies from the NHL/LM GWAS
|
ZIA CP010136-10799
|
$134,022
|
$13,402
|
Berndt, Sonja
|
DCEG (NCI)
|
|
|
Genomics of multiple primary tumors
|
ZIA CP010131-10782
|
$214,814
|
$21,481
|
Morton, Lindsay
|
DCEG (NCI)
|
|
|
Hematopathology Diagnosis
|
ZIA BC 011070
|
$656,574
|
$196,972
|
Jaffe, Elaine
|
CCR (NCI)
|
|
|
Hematopathology Fellowship
|
ZIE BC 011241
|
$410,358
|
$102,590
|
Jaffe, Elaine
|
CCR (NCI)
|
|
|
Hemopoietic malignancies among persons exposed to low and moderate ionizing radia
|
ZIA CP010170-10715
|
$77,974
|
$7,797
|
Little, Mark
|
DCEG (NCI)
|
|
|
High dose/high dose rate radiobiological and radioepidemiological data
|
ZIA CP010131-10595
|
$8,056
|
$1,208
|
Little, Mark
|
DCEG (NCI)
|
|
|
HIV and Cancer
|
ZIA CP010150-10071
|
$90,450
|
$13,567
|
Engels, Eric
|
DCEG (NCI)
|
|
Total relevant funding to Hodgkins disease for this search: $13,018,548
|
